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Aims The adaptation of the myocardial microcirculation in humans to pathologic and physiologic stress
has not been examined in vivo so far. We sought to test whether the relative blood volume (rBV)
measured by myocardial contrast echocardiography (MCE) can differentiate between left ventricular
(LV) hypertrophy (LVH) in hypertensive heart disease and athlete’s heart.
Methods and results Four groups were investigated: hypertensive patients with LVH (n ¼ 15), semi-
professional triathletes with LVH (n ¼ 15), professional football players (n ¼ 15), and sedentary
control individuals without cardiovascular disease (n ¼ 15). MCE was performed at rest and during
adenosine-induced hyperaemia. The rBV (mL mL21), its exchange frequency (b, min21), and myocardial
blood ﬂow (mL min21 g21) were derived from steady state and reﬁll sequences of ultrasound
contrast agent. Hypertensive patients had lower rBV (0.093+ 0.013 mL mL21) than triathletes
(0.141+ 0.012 mL mL21, P, 0.001), football players (0.129+ 0.014 mL mL21, P, 0.001), and seden-
tary individuals (0.126+ 0.018 mL mL21, P, 0.001). Conversely, the exchange frequency (b) was
signiﬁcantly higher in hypertensive patients (11.3+ 3.8 min21) than in triathletes (7.4+ 1.8 min21),
football players (7.7+ 2.3 min21), and sedentary individuals (9.0+ 2.5 min21). An rBV below
0.114 mL mL21 distinguished hypertensive patients and triathletes with a sensitivity of 93% and a
speciﬁcity of 100%.
Conclusion Pathologic and physiologic LVH were differentiated non-invasively and accurately by rBV,
a measure of vascularisation assessed by MCE.
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Introduction
Left ventricular (LV) hypertrophy (LVH) is a structural and
functional adaptation to increased wall stress. In patients
with hypertensive heart disease, the presence of LVH is a
strong predictor of future cardiac events and all-cause
mortality.1–3 In athlete’s heart, on the contrary,
training-induced LVH is believed to pose no such risk and
physical ﬁtness reduces all-cause mortality.4 Pathologic
LVH due to pressure overload by systemic hypertension
arises from hypertrophy of myocytes and extravascular
collagen deposition,5 which stiffens the LV and impairs
diastolic ﬁlling.6 Biopsies demonstrated a reduction of
arterioles and capillaries relative to the surrounding
tissue.7,8 The arterioles’ capacity to dilate is attenuated
and consequently, the coronary vasodilator reserve is
reduced.9,10 Furthermore, epicardial coronary arteries do
not adequately increase in size with the extent of LVH.11
In athlete’s heart, depending on the predominance of
dynamic and/or static-exercise, volume and/or pressure
load exerts LV wall stress, which is compensated by LVH,
either eccentric or concentric, albeit this concept is rather
relative.12–14 The physiologic nature of exercise-induced
LVH has been conﬁrmed by normal systolic and diastolic
cardiac function and metabolism, and supernormal coronary
vasodilator reserve.15–17 Epicardial coronary arteries
increase proportionally in size with LV mass.18,19 Although
these two forms of LVH are associated with ‘bad’ or ‘good’
outcome, the adaptation of myocardial microcirculation to
increased wall stress remains to be investigated due to the
lack of a suitable measurement technique. Recently, we
demonstrated that myocardial contrast echocardiography
(MCE) accurately measures the myocardial blood ﬂow
(MBF) via determination of the underlying microvascular
parameters, relative blood volume (rBV), and its exchange
frequency (b).20 The rBV corresponds to the intravascular
volume fraction and thus reﬂects the capillary density.
The exchange frequency (b) reﬂects the turnover of rBV
and is a measure of the resistance to MBF. The current
investigation, was set up to clarify the postulated
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differences of the microvascular response in hypertensive
and athletic LVH.
Methods
Study population
For this pilot study, we included 15 individuals in each of the four
groups: hypertensive patients with LVH (n ¼ 15), semi-professional
triathletes with LVH (n ¼ 15), professional football players
(n ¼ 15), and sedentary control individuals without cardiovascular
disease (n ¼ 15). We initially screened the semi-professional triath-
lete teams, and then evaluated the age (range+ 2 years) and
gender matched hypertensive patients with suspected LVH from
the out-patient clinic of the Department of Nephrology and
Hypertension. As control groups, sedentary individuals from the hos-
pital staff and medical students, as well as members of a swiss pre-
miere league football team were included. However the matching
criteria could not be perfectly met for the latter, as they were all
male and within a small range of age.
The reasons for ineligibility were the lack of LVH (nine hyperten-
sive patients, 14 triathletes) and the presence of cardiovascular risk
factors (one triathlete, four football players, ﬁve sedentary indivi-
duals). All eligible individuals were included and completed the
study examinations.
All participants had no history of cardiac or pulmonary disease
or cardiovascular risk factors except arterial hypertension in
patients, deﬁned as: systolic and diastolic blood pressure of .140
and .90 mmHg, respectively, in both ofﬁce cuff and 24 h ambula-
tory blood pressure monitoring, or the need of antihypertensive
drug therapy to maintain normotension. The study protocol was
approved by the Ethics Committee of the University of Bern, and
all individuals gave written informed consent to participate in the
study.
Study protocol
Anaemia or hypercholesterolaemia were excluded by blood
samples. All subjects abstained from methyl-xanthines including
caffeine 24 h before the study and were studied after an overnight
fasting period. Baseline echocardiography was performed in all
participants to exclude signiﬁcant valvulopathies or shunts. LVH
was assessed by two-dimensional echocardiography according
to the Teichholz formula as LV mass index exceeding 134 g m22
and 109 gm22 in men and women, respectively; a ratio of septal
plus posterior wall thickness to LV cavity dimension in diastole
greater than 0.45; an end-diastolic septal or posterior wall thickness
12 mm. The participants subsequently underwent MCE at rest and
during adenosine-induced hyperaemia. Images were obtained from
apicals chamber views.
Myocardial contrast echocardiography
Data acquisition
A Sequoia C512 ultrasound scanner (Siemens Medical Solutions,
Mountain View, CA, USA) equipped with a 4V1c transducer and the
contrast echo software CPS (Coherent Pulse Sequences) was used
for real-time MCE. The machine settings were as follows: mechani-
cal index (MI) for microsphere detection 0.13, MI for microsphere
destruction 1.3, dynamic range 50 dB, linear post-processing, clip
length 300 and 200 frames with intervals of 75 ms for rest and
stress imaging, respectively.
Ultrasound contrast agent V08DA (SonoVue, Bracco SA, Mendrisio,
Switzerland) was infused into the right cubital vein at a rate of
0.5–1 mL min21. At rest, saline was infused at a rate of
2.8 mL kg21 h21 as a substitute for the adenosine infusion in order
to obtain the same steady state concentration of the contrast
agent in the intravascular compartment as during hyperaemia.
When stable myocardial enhancement was reached, the contrast
infusion rate was kept constant, and baseline image acquisition
was performed. Steady state and reﬁll sequences of contrast
agent were derived before and after microsphere destruction,
respectively. After completion of resting perfusion sequences, con-
trast and saline infusion were stopped, and hyperaemia was induced
by intravenous adenosine 140 mg kg21 min21 (adenosine 3 mg mL21
diluted in NaCl 0.9%) via a parallel port resulting in an infusion
rate of 2.8 mL kg21 h21. After 3 min of adenosine infusion, contrast
infusion was started at the same rate as in the resting study. After
6 min of adenosine infusion, hyperaemia perfusion sequences were
obtained.
Data analysis
Ofﬂine image analysis and quantiﬁcation were done with DataPro
2.11 (Noesis S.A., Courtaboeuf, France). Logarithmic signal com-
pression was removed, and linearized signal intensity data were
expressed in arbitrary units. MBF was calculated as previously
described and validated by our group.20 Only the end-systolic
frames were selected for analysis. Corresponding to the territories
of the main coronary arteries, regions of interest (ROI) were
placed in mid-septal, mid-lateral, and mid-inferior segments. The
ROIs were tracked manually within the myocardium and in the
adjacent LV cavity. Myocardial intensity data were corrected for
non-contrast signals arising from the tissue by subtracting the
signal intensity of the ﬁrst frame after manual bubble destruction
(MBD). Myocardial plateau signal intensity A was calculated by ave-
raging the myocardial signal intensity data from end-systolic frames
before MBD. Averaging adjacent LV signal intensities of all end-
systolic frames except the ones during and the ﬁrst after MBD
yielded the signal intensity in the nearby LV ALV; rBV in mL mL
21
(%) was calculated according to Equation (1)
rBV ¼ A
A LV
: ð1Þ
The exchange frequency (b, min21) was derived from the
ﬁtting of myocardial intensity data after MBD to the reﬁll equation
[Equation (2)]
y(t) ¼ A  ð1 ebtÞ: ð2Þ
The product of rBV and exchange frequency (b) divided by tissue
density (1.05 g mL21) yielded MBF. Myocardial blood ﬂow reserve
(MBFR) was calculated as the ratio of hyperaemic and resting MBF.
Bicycle spiroergometry
All participants performed a bicycle spiroergometry starting at a
workload of 100 Watt with a ramp protocol and increasing every
minute by 15 Watt until exhaustion. Oxygen uptake (VO2,
mL kg21 min21) and heart rate were continuously measured and
sphygmomanometric blood pressure was obtained every 3 min.
Peak VO2 was deﬁned as the highest VO2 achieved during the last
30 s of peak exercise.
Statistical methods
Data were expressed as mean value+ standard deviation. Only one
measure per patient, i.e. the arithmetic mean of the three assess-
ments obtained for the septal, lateral, and inferior segment, was
used for further statistical analysis. All tests were two-sided.
Repeated-measures analysis of variance (ANOVA) was performed
for participant characteristics, echocardiographic, and MCE data.
In case of a signiﬁcance, paired t-tests were used for post-hoc
analyses. In MCE data, uncorrected P-values were indicated for pre-
deﬁned pairwise comparisons (i.e. between hypertensive patients
and triathletes, hypertensive patients and sedentary individuals,
as well as triathletes and football players), whereas for the remain-
ing pairwise and not predeﬁned comparisons, P-values were
adjusted for multiple testing by Holm’s procedure.
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Linear regression analysis was carried out for the detection of
correlation between MBFR and maximal oxygen uptake, as well as
maximal workload, respectively. Receiver-operating-characteristics
analyses were used to assess the accuracies of rBV and exchange
frequency (b). Statistical signiﬁcance was deﬁned at P, 0.05.
Results
Participant characteristics and
echocardiographic data
The characteristics of the study population are shown
in Table 1. In the group with hypertensive heart disease,
12 patients had essential hypertension and three an under-
lying renal disease (IgA nephropathy, n ¼ 2; renal artery
stenosis, n ¼ 1) without signiﬁcant renal functional impair-
ment. All patients were on antihypertensive therapy:
angiotensin-converting enzyme inhibitors, n ¼ 7; angioten-
sin receptor antagonists, n ¼ 6; beta-blockers, n ¼ 6;
calcium antagonists, n ¼ 4; diuretics, n ¼ 7. There was no
statistical difference among the age of the groups. Body
mass index was signiﬁcantly higher in hypertensive than in
other subjects. Hypertensive patients had systolic hyperten-
sion, and an increased rate pressure product. During
adenosine-induced hyperaemia, heart rate signiﬁcantly
increased in all groups (hypertensive patients P, 0.001,
triathletes P ¼ 0.002, football players P ¼ 0.03, and seden-
tary individuals P, 0.001) and so did the rate pressure
product (hypertensive patients P , 0.001, triathletes
P ¼ 0.02, football players P ¼ 0.046, and sedentary individ-
uals P ¼ 0.003).
Echocardiographic data are summarized in Table 2. LV
ejection fraction (EF) was not different among the groups.
Hypertensive patients showed several transmitral and
mitral annular Doppler parameters indicative of LV diastolic
dysfunction, whereas the other groups (in particular the
triathletes) did not.
MCE data
Analysis was feasible in 160 of 180 investigated seg-
ments and success rate of mid-septal, mid-lateral, and
mid-inferior regions was 100, 67, and 100%, respectively.
MBF at rest (Figure 1A) was not different among the
groups (hypertensive patients 0.97+ 0.27 mL min21 g21,
triathletes 0.95+ 0.21 mL min21 g21, football players
0.90+ 0.22 mL min21 g21, and sedentary individuals
1.04+ 0.27 mL min21 g21). In contrast, MBF during
hyperaemia (Figure 1B) was lower in hypertensive
patients (2.55+ 0.70 mL min21 g21) than in triathletes
(4.53+ 1.05 mL min21 g21, P, 0.001), football players
(3.53+ 0.085 mL min21 g21, P, 0.01), and sedentary
individuals (3.38+ 0.86 mL min21 g21, P ¼ 0.005). Conse-
quently, MBFR was lower in hypertensive patients
(2.75+ 0.32) than in triathletes (4.96+ 1.17; P, 0.001)
and football players (4.20+ 1.19; P, 0.001), but not sig-
niﬁcantly different compared with the sedentary individuals
(3.38+ 0.70; P ¼ 0.14). In triathletes, MBFR was higher
than in sedentary individuals (P, 0.001) but not compar-
able with football players (P ¼ 0.111).
The exchange frequency (b) at rest (Figure 2A) was higher
in hypertensive patients (11.3+ 3.8 min21) than in triath-
letes (7.4+ 1.8 min21), football players (7.7+ 2.3 min21),
and sedentary individuals (9.0+ 2.5 min21). During
hyperaemia (Figure 2B), the exchange frequency (b) in
hypertensive patients, triathletes, football players, and
Table 1 Participant characteristics and haemodynamic data
Hypertensive patients Triathletes Football players Sedentary individuals ANOVA
Number (women)
Evaluated 24(2) 30(3) 19(0) 20(1)
Ineligible 9(1) 15(2) 4(0) 5(0)
Included 15(1) 15(1) 15(0) 15(1)
Age, years 33+ 9 33+ 9 27+ 4 32+ 8 0.18
Body mass index, kg m22 26.6+ 3.9T**,F*,S** 22.0+ 0.8F** 24.1+ 1.1 22.8+ 2.5 ,0.001
Rest
Heart rate, min21 65(64)+10T* 56(56)+ 5S* 60(60)+ 6 67(68)+ 10 0.005
Systolic blood pressure,
mmHg
143(137)+ 17T**,F**,S** 121(120)+ 10S* 119(120)+8 S* 111(113)+ 10 ,0.001
Diastolic blood pressure,
mmHg
82(82)+ 16T*,F**,S** 73(76)+ 9S* 69(65)+ 10 64(65)+ 11 ,0.001
Rate pressure product,
min21 mmHg
9418(8505)+ 2444T**,F**,S* 6814(6724)+ 827 7102(7018)+ 789 7509(7202)+ 1450 ,0.001
Hyperaemia
Heart Rate, min21 90(87)+ 13T**,F** 67(65)+ 13S** 69(72)+ 15S* 82(80)+ 13 ,0.001
Systolic blood pressure,
mmHg
135(137)+ 9T**,F**,S** 115(114)+ 11 119(120)+ 12S* 109(107)+ 10 ,0.001
Diastolic blood pressure,
mmHg
76(73)+ 9T*,F*,S** 66(65)+ 12 65(66)+ 11 62(63)+ 11 0.002
Rate pressure product,
min21 mmHg
12221(12400)+ 2119T**,F**,S** 7697(7410)+ 1613S* 8244(7776)+ 2266 8961(9095)+ 1708 ,0.001
ANOVA repeated-measures analysis of variance, if signiﬁcant two-sided t-tests were performed for pairwise comparisons. Values are denoted as
mean(median)+ standard deviation or number. T, F, and S denote comparison with triathletes, football players, and sedentary individuals, respectively.
*P , 0.05, **P , 0.01.
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sedentary individuals were 24.6+ 6.4, 32.9+ 7.5,
24.3+ 5.1, and 22.7+ 5.1 min21, respectively. Triathletes
had a higher exchange frequency (b) during hyperaemia
compared with the other groups. Exchange frequency (b)
of hypertensive patients, triathletes, football players,
and sedentary individuals increased signiﬁcantly from
rest to stress by a factor of 2.28+ 0.57, 4.58+ 0.98,
3.37+ 0.98, and 2.64+ 0.69, respectively. Accuracy of
the resting exchange frequency (b) was poor for the distinc-
tion between hypertensive heart disease and athlete’s heart
(best cut-off 8.15 min21, sensitivity 73%, speciﬁcity 80%,
area under the curve 0.83, positive predictive value 79%,
negative predictive value 75%), respectively, sedentary indi-
viduals (best cut-off 10.0 min21, sensitivity 53%, speciﬁcity
Table 2 Echocardiographic data
Hypertensive patients Triathletes Football players Sedentary individuals ANOVA
LV EF, % 64+ 4 65+ 3 64+ 2 65+ 3 0.50
Interventricular septum
(ED), mm
15.7+ 2.6T**,F**,S** 13.3+ 1.6F**,S** 11.1+ 1.0S* 10.2+ 0.7 ,0.001
Posterior wall (ED), mm 13.6+ 1.8T**,F**,S** 11.9+ 1.8F**,S** 10.5+ 0.6S* 9.7+ 0.8 ,0.001
LV (ED) diameter, mm 46.2+ 6.5F** 49.9+ 4.1 51.3+ 2.9S** 48.6+ 3.9 0.03
LV mass index, g m22 140+ 30F**,S** 134+ 15F**,S** 108+ 14S** 94+ 13 ,0.001
Left atrial diameter, mm 38.7+ 3.6 39.6+ 5.0 37.8+ 3.8 35.3+ 4.7 0.06
Diastolic parameters
Early diastolic peak
velocity (E), cm s21
72.3+ 17.5 73.1+ 12.6 66.5+ 10.3 70.2+ 10.4 0.59
Late diastolic peak
velocity (A), cm s21
65.7+ 12.9T**,F**,S** 44.9+ 10.5 39.6+ 5.4 44.5+ 11.7 ,0.001
E/A 1.16+ 0.45T*,F*,S* 1.68+ 0.38 1.70+ 0.30 1.66+ 0.42 ,0.007
Deceleration time of E, ms 198+ 40F** 184+ 24F** 153+ 26 169+ 20 ,0.001
Isovolumertic relaxation
time, ms
97+ 26 83+ 15 84+ 11 85+ 11 0.07
Mitral annular E velocity
TDI, cm s21
7.5+ 1.4 12.0+ 2.4 13.0+ 3.0 10.4+ 1.6 0.85
Mitral annular A velocity
TDI, cm s21
9.7+ 1.9 10.3+ 3.0 8.0+ 1.5 9.3+ 2.5 0.38
ANOVA repeated-measures analysis of variance, if signiﬁcant two-sided t-tests were performed for pairwise comparisons. Values are denoted as
mean(median)+ standard deviation or number. T, F, and S denote comparison with triathletes, football players, and sedentary individuals, respectively.
*P, 0.05, **P , 0.01.
Figure 1 MBF (mL min21 g21) at rest (A) and during adenosine-induced hyperaemia (B) in hypertensive patients with LVH (n ¼ 15), semi-professional triathletes
with LVH (n ¼ 15), professional football players (n ¼ 15), and sedentary individuals (n ¼ 15). Boxplot shows each outlier as an open circle.
1574 A. Indermu¨hle et al.
73%, area under the curve 0.68, positive predictive value
67%, negative predictive value 61%).
At rest (Figure 3A), rBV was lower in hypertensive
patients (0.093+ 0.013 mL mL21) than in triathletes
(0.141+ 0.012 mL mL21), football players (0.129+ 0.014
mL mL21), and sedentary individuals (0.126+ 0.018
mL mL21). During hyperaemia (Figure 3B), rBV was lower
in hypertensive patients (0.111+ 0.021 mL mL21) compared
to triathletes (0.151+ 0.026 mL mL21), and football players
(0.157+ 0.026 mL mL21) but not compared with sedentary
individuals (0.159+ 0.017 mL mL21, P , 0.06). In all
groups except triathletes, rBV increased signiﬁcantly from
rest to stress by a factor of 1.21+ 0.25 in hypertensive
patients, 1.07+ 0.18 in triathletes, 1.22+ 0.20 in football
players, and 1.28+ 0.17 in sedentary individuals. At rest,
an rBV of 0.114 mL mL21 distinguished hypertensive patients
and triathletes with a sensitivity of 93% and a speciﬁcity of
100% (area under the curve 0.99, positive predictive value
100%, negative predictive value 94%); an rBV of
0.107 mL mL21 distinguished hypertensive patients and
sedentary individuals with a sensitivity 93% and a speciﬁcity
of 87% (area under the curve 0.94, positive predictive value
88%, negative predictive value 93%).
A positive linear relationship with modest correlation
was found between MBFR and maximal oxygen uptake
(y ¼ 0.050xþ 1.476, r2 ¼ 0.33, P, 0.001), the maximal
workload achieved in Watt per kilogram (y ¼ 0.007xþ
1.574, r2 ¼ 0.305, P, 0.001).
Discussion
This study investigated the myocardial microvascularisation
by quantiﬁcation of rBV, i.e. the regional blood volume rela-
tive to the surrounding tissue. Hypertensive patients had
reduced rBV, which was compensated by increased exchange
frequency (b) of this volume and consequently, MBF at rest
was normal. Thus, pathologic LVH in hypertensive patients
is accurately and non-invasively distinguishable from physio-
logic LVH in an athlete’s heart using MCE.
Hypertensive heart disease
Patients with hypertension-induced LVH may suffer from
myocardial ischaemia, ventricular dysfunction, causing
congestive heart failure and lethal arrhythmias.2,5
Structural abnormalities of the heart such as reduced
myocardial capillary density, inadequately sized epicardial
coronary arteries, as well as periarteriolar and ventricular
ﬁbrosis have been identiﬁed,8 and lead to reduced
MBFR. However, impaired MBFR may either be due to
coronary artery stenosis or microvascular disease. MBF can
be measured non-invasively by positron emission tomo-
graphy and lately by MCE,20 which provides additional infor-
mation on the microcirculation, i.e. the rBV and its
exchange frequency (b). We found that MBF at rest was
similar in hypertensive patients compared with the other
groups, a ﬁnding, which is in line with the recent PET
studies.10,21,22
Capillary density can be estimated by rBV as 90% of myo-
cardial blood volume resides at this level of the circula-
tion.23 The reduced rBV in our hypertensive patients
therefore reﬂects inadequate growth of capillaries, which
may be explained by constant mechanical stress favouring
collagen deposition whereas intermittent exercise in ath-
letes leaves the heart enough time to adapt physiologically.
In contrast, Di Bello et al.24 found no difference in peak
signal intensity, a surrogate measure for rBV, and in the
exchange frequency between patients with hypertensive
heart disease and controls. However, to equate rBV with
peak signal intensity is not entirely correct because the
latter depends on variations in contrast agent concentration
and different acoustic properties in patients, and therefore,
corresponds only loosely to rBV. The fact that they found no
difference in exchange frequency (b) may be explained by
Figure 2 Exchange frequency (b, min21) at rest (A) and during adenosine-induced hyperaemia (B). Boxplot shows each outlier as an open circle.
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their use of intermittent imaging, which prolongs the inter-
vals of contrast agent destruction.
We found in our study, that MBFR in all groups was pre-
dominantly governed by an increase of exchange frequency
(b) and only to a smaller extent by an increase of rBV (e.g.
increase in hypertensive patients: exchange frequency (b)
2.28-fold, rBV 1.21-fold). In hypertensive patients, the
reserve in exchange frequency (b) was lower due to the
increased exchange frequency (b) at rest, therefore MBFR
was reduced compared with triathletes and football
players. Hamasaki et al.9 showed with intracoronary
Doppler reduced coronary ﬂow reserve in patients with
hypertensive heart disease compared to controls. This may
be explained by them having included older and sympto-
matic patients referred for cardiac catheterization. Unlike
them, we did not include patients with cardiovascular risk
factors other than hypertension. In our hypertensive
patients, rBV more accurately detected microvascular
dysfunction than MBFR, which was still normal.
Athlete’s heart
In athlete’s heart, on the contrary, training-induced LVH is
believed to be benign and physical ﬁtness has been shown
to reduce the all-cause mortality.4 Cardiac function such
as MBFR is supernormal. Therefore, it was assumed that
myocytes as well as the surrounding vasculature grew in
proportion. Nevertheless, this interpretation remained
hypothetical as myocardial biopsies are not available due
to ethical reasons. In this respect, rBV allows non-invasive
assessment of the degree of vascularisation and its func-
tional response to vasodilators. In triathletes, rBV at rest
(0.141+ 0.012 mL mL21) was higher than in hypertensive
patients (0.093+ 0.013 mL mL21) but also in comparison
to sedentary individuals (0.126+ 0.018 mL mL21) without
LVH. White et al.25 showed with morphometry in a porcine
model that exercise training increased total cross-sectional
vascular bed area by 37% after 16 weeks. Thus, our results
add to the idea of a myocardial vasculature growth out of
proportion in endurance exercise-induced LVH as compared
to controls, to meet the increased metabolic demands.
This is in accordance with the theoretically described and
practically conﬁrmed power-law relationship between the
epicardial coronary artery cross-sectional area and the
dependent, downstream myocardial mass.19
Apart from our current results, two studies examined MBF
and MBFR in athlete’s heart with conﬂicting results. Using
positron emission tomography, Takala et al.26 found in nine
athletes that MBF at rest was 33% lower than in controls
and speculated that energy metabolism would be more efﬁ-
cient, however, the small number suggests a random ﬁnding.
In contradiction, Toraa et al.17 found no such difference,
neither did we in the present study. MBFR of our triathletes
(5.0+ 1.6) was in the same range as in these studies.17,18
The higher value (6.1+ 1.9) in the study by Toraa et al.
may be explained by the higher LV mass index, reﬂecting a
higher ﬁtness level compared with our triathletes.
As expected, the high MBFR in triathletes, the subjects
with the most intense aerobic endurance training, was
due to an extreme increase in exchange frequency (b,
4.55-fold), and only little was contributed by an increase
in rBV (1.11-fold). Adenosine relaxes smooth muscle cells
of resistance vessels, and thereby decreases the resistance
to ﬂow. Therefore, it can be speculated that the increase
in exchange frequency (b) inversely correlates with resist-
ance to ﬂow. In dogs, it has been shown that exercise train-
ing increases resistance vessels’ sensitivity and maximal
responsiveness to adenosine.27–29
Comparison with other techniques
So far, no other imaging technique has been validated for
the measurement of rBV in humans. Magnetic resonance
imaging uses the detection of longitudinal relaxation
Figure 3 rBV (%) at rest (A) and during adenosine-induced hyperaemia (B). Boxplot shows each outlier as an open circle.
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changes (T1) during the inﬂow of arterial blood and corrects
for an assumed ratio of haematocrit in capillaries and the
ventricle.30,31 The use of such a correction factor restricts
the quantitation of MBF and rBV. Also the BOLD (blood
oxygenation level-dependent) method only provides a
qualitative measurement of rBV changes.32 Attempts have
been made to calculate rBV by electron-beam computed
tomography using signal intensity curves. rBV was deter-
mined indirectly by measuring perfusion, and using a
model with recruitable and non-recruitable blood volumes
with coefﬁcients that needed to be determined experimen-
tally.33 This method further suffers from the dissolution of
tracers into the extravascular space, which distorts signal
intensity curves. Finally, its use has to be restricted due to
the radiation exposure (especially in followup-studies). Wu
et al.34 calculated myocardial blood volume in dogs by
dividing MBF derived from radio-labeled microspheres with
exchange frequency derived from MCE. Thus, two
techniques were used non-simultaneously to calculate
myocardial blood volume.
Yano et al.35 estimated myocardial blood volume to be
4.0+ 2.2 and 0.6+ 0.3% in normal and akinetic myocar-
dium, respectively. This low values most likely arose from
their signal decompression, as they divided the negative
exponent by 10 instead of 20. Moreover, they used intermit-
tent imaging with a pulsing interval of four heartbeats,
which might be too short to allow steady state capillary
ﬁlling. Instead, we demonstrated by real-time MCE in a
ﬂow phantom with known intrvascular volume that rBV
equals the ratio of decompressed (division with factor 20
in the exponent) signal intensities in the myocardium and
adjacent LV after background correction.20
Limitations
According to the matching criteria, young patients (33+9
years) with long-standing hypertension were included, and
consequently all of them were on antihypertensive
therapy. The inﬂuences of antihypertensive drugs on MBF
and coronary vasodilatator reserve were examined only in
a small number of studies, which mainly found that
angiotensin-converting enzyme inhibitors improved coro-
nary vasodilatator reserve.36,37 However, the effects on
the rBV are unknown, but this parameter might serve as a
new endpoint for the assessment of changes in myocardial
structure.
Although we studied young asymptomatic patients,
coronary angiography was not performed, and thus, it
cannot be excluded that the presence of early-stage athero-
sclerosis may have biased our results. However, relevant
coronary atherosclerosis is unlikely given the fact that
cardiovascular risk factors other than hypertension were
absent and MBFR was normal in 32 of 39 analysable coronary
artery territories.
MCE with its purely intravascular tracer has to be
considered as the reference method for the in vivo measure-
ment of rBV in humans. However, a comparison to another
technique is still lacking and in this respect, measurements
based on myocardial biopsies need to be interpreted care-
fully because ﬁlling of the vasculature is affected by the
ﬁxation process and therefore does not correspond to the
one in vivo.
Conclusion
Myocardial microvascularisation, i.e. rBV, measured by MCE
accurately differentiates between LVH in hypertensive
patients and athletes, respectively. Potential future clinical
applications of rBV could be the non-invasive differentiation
of reduced MBFR in coronary artery disease and
microvascular disease; controlling the reversibility of
hypertensive heart disease under antihypertensive treat-
ment; and the monitoring of clinical trials promoting myo-
cardial angiogenesis. This parameter might be as well
useful for the distinction between athlete’s heart and hyper-
trophic cardiomyopathy because myocardial biopsies have
indicated that arteriolar and capillary density are even
more reduced in hypertrophic cardiomyopathy than in
hypertensive heart disease.8
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